![CARTIA XT® brand of DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP(ONCE-A-DAY DOSAGE)Rx only CARTIA XT® brand of DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP(ONCE-A-DAY DOSAGE)Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-5.jpg&id=593418)
CARTIA XT® brand of DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP(ONCE-A-DAY DOSAGE)Rx only
![Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider](https://mma.prnewswire.com/media/1017870/Health_Canada_Information_Update___Additional_ranitidine_product.jpg)
Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider
![Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider](https://mma.prnewswire.com/media/1017872/Health_Canada_Information_Update___Additional_ranitidine_product.jpg)
Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider
![Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider](https://mma.prnewswire.com/media/1017876/Health_Canada_Information_Update___Additional_ranitidine_product.jpg)
Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider
![Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider](https://mma.prnewswire.com/media/1017873/Health_Canada_Information_Update___Additional_ranitidine_product.jpg)
Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider
![Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider](https://mma.prnewswire.com/media/1017878/Health_Canada_Information_Update___Additional_ranitidine_product.jpg)
Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider
![Teva UK is latest pharmaceutical giant to recall batches of heartburn drug Zantac | Daily Mail Online Teva UK is latest pharmaceutical giant to recall batches of heartburn drug Zantac | Daily Mail Online](https://i.dailymail.co.uk/1s/2019/10/17/15/19842012-0-image-a-33_1571323057627.jpg)
Teva UK is latest pharmaceutical giant to recall batches of heartburn drug Zantac | Daily Mail Online
![These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-53.jpg&id=753005)
These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for
![Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider](https://mma.prnewswire.com/media/1017877/Health_Canada_Information_Update___Additional_ranitidine_product.jpg)
Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA | Markets Insider
![Information Update - Additional ranitidine products recalled, including Zantac; request to stop distribution remains in place while Health Canada continues to assess NDMA Information Update - Additional ranitidine products recalled, including Zantac; request to stop distribution remains in place while Health Canada continues to assess NDMA](https://mma.prnewswire.com/media/1013701/Health_Canada_Information_Update___Additional_ranitidine_product.jpg?p=facebook)